- Digg
- Google Bookmarks
- StumbleUpon
- Newsvine
- Live Bookmarks
- Technorati
- Yahoo Bookmarks
- Blogmarks
- Del.icio.us
- ApnaCircle
- Google Plus
ETMarkets.com|
Updated: Jun 15, 2018, 10.20 AM IST
Company Summary
ADD TO PORTFOLIO
ADD TO WATCHLIST
SHARE YOUR OULOOK
ChartsValuation & Peer ComparisonCommunity Buzz
Elara Capital has a reduce call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 482 . The current market price of Sun Pharmaceutical Industries Ltd. is Rs 569.25 Time period given by the brokerage is a year when Sun Pharmaceutical Industries Ltd. price can reach defined target. .
Sun Pharmaceutical Industries Ltd., incorporated in 1993, is a largecap company with a market cap of Rs 134278.20 crore.
Investment rationale by Elara Capital
Halol clearance provides comfort on Suns achievement of guidance of early double-digit revenue growth in FY19. Focus would shift back to earnings quality and ramp-up in the specialty business. The stock has seen a 10% run-up over past three trading days post FDA status of VAI on the Halol facility. At the CMP, the stock is trading at rich valuations of 25x FY20E P/E and factors in the Halol clearance, in our view. We retain Reduce with a TP of INR 482 based on 22x FY20E P/E.
Read this article in :HindiRead more on
Also Read
Reduce CESC, target Rs 970: Elara Capital
Accumulate Cyient, target Rs 900: Elara Capital
Accumulate Tata Motors, target Rs 362: Elara Capital
Accumulate ABB India, target Rs 1390: Elara Capital
3 IT stocks Ravi Menon of Elara Capital is bullish on
Commenting feature is disabled in your country/region.
Disclaimer: This recommendation is analyst's own and does not represent those of economictimes.com & ETMarkets.com. Please consult your financial advisor before taking any position in the stock/s mentioned.
From Around The Web
More from The Economic Times
[contf] [contfnew] 
ET Markets
[contfnewc] [contfnewc]
